<DOC>
	<DOCNO>NCT01972464</DOCNO>
	<brief_summary>Smoking main preventable cause mortality Western country , contribute 430,000 deaths year U.S. alone . Clinical epidemiological study show woman often decrease smoke pregnancy , progesterone level high . However , least half resume pre-pregnancy smoking level within week delivery progesterone level drop . Data preclinical clinical study suggest progesterone may effective prevent relapse smoke non-postpartum woman . Prior work show progesterone decrease crave cigarette subjective rewarding effect smoke among recently abstinent female smoker . These finding lead u hypothesize progesterone may efficacy relapse prevention treatment postpartum woman . We propose 8-week , randomize pilot study evaluate safety initial efficacy progesterone . This feasibility study compare progesterone placebo relapse prevention 40 postpartum smoker . We assess feasibility safety , include potential effect breastfeed infant expose via breast milk , addition 7-day point prevalence smoke abstinence 8 week treatment follow-up , 3-months end protocol .</brief_summary>
	<brief_title>Progesterone Postpartum Smokers</brief_title>
	<detailed_description />
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Need within 3 week delivery relapse smoking happen early childbirth Aged 18 42 year history smoking , smoke nicotine product abstinence achieve final two month pregnancy delivery In good health verify medical history Using acceptable birth control method hormonal contraceptive contain progestin Have biologically confirm abstinence tobacco nicotine product randomization A history major medical illness include liver disease , suspect known malignancy , thrombophlebitis , liver failure , medical condition physician investigator deems make study participation unsafe subject Current past history bipolar disorder schizophrenia current diagnosis major depression , panic disorder posttraumatic stress disorder Dependence and/or abuse alcohol drug abuse month prior randomization trial presence suicidal homicidal ideation , significant impairment social occupational functioning , either study baseline evaluation process , participation trial inability speak Spanish English ( group bilingual ) plan move area within 8 month study screen since make followup difficult Inability understand study procedure provide inform consent Currently undergo treatment another pharmacological agent smoke cessation pending legal case may result incarceration since would force abstinence impede followup ; Pending case child protective service might lead removal infant mother 's custody , would impede breastfeed infant followup Unwilling accept randomization Subsequent pregnancy since would another source progesterone An acute general medical condition would require imminent rehospitalization since would enforce abstinence ( woman may randomize discharged still within recruitment window ) Allergy progesterone peanut ( vehicle micronized progesterone ) Currently undergo treatment ketoconazole know strong CYP3A4 inhibitor</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Progesterone</keyword>
	<keyword>Placebo</keyword>
	<keyword>Postpartum</keyword>
	<keyword>Tobacco</keyword>
	<keyword>Pregnancy</keyword>
</DOC>